Authors: J. Špaček 1; Z. Veselský 2; J. Tošner 1; Z. Tesařík 3 Authors‘ workplace: Porodnická a gynekologická klinika, FN v Hradci Králové, přednosta doc. MUDr. J. Tošner, CSc. 2Urologická klinika, FN v Hradci Králové, přednosta doc. MUDr. P. Morávek, CSc. 3Bristol-Myers Squibb, s. r. o. Onkologická divize, Praha 1 Published in: Ceska Gynekol 2003; (2): 99-105 Category:
Objective: To present a review of para-aortic lymphadenectomy in gynecology.Subject: Review.Setting: Department of Obstetrics and Gynecology, Department of Urology, Medical Faculty HradecKrálové, Charles University, Prague; Bristol-Myers Squibb, Department of Oncology, Prague.Subject and Method: Discussion about current evidence from literature and our own experience.Conclusion: In the past 20 years, pelvic and paraaortic lymphadenectomy has become part of thestandard surgical treatment of ovarian cancer. Overall, about 40% of patients with ovarian cancerwill have nodal involvement. Regarding to this real probability is para-aortic lymphadenectomyvery important part of surgical treatment in this disease.
Key words: para-aortic lymphadenectomy, ovarian cancer, metastatic involvement
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
